Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

被引:0
|
作者
Eissa, Eman [1 ]
Morcos, Botros [1 ]
Dorgham, Dalia [2 ]
Kholoussi, Naglaa [1 ]
机构
[1] Natl Res Ctr, Dept Immunogenet, Cairo, Egypt
[2] Cairo Univ, Fac Med, Dept Rheumatol & Rehabil, Cairo, Egypt
关键词
Complement factor H; factor H autoantibodies; juvenile-onset systemic lupus erythematosus; nephritis; DISEASE-ACTIVITY; BINDING-SITES; ACTIVATION; PRODUCTS; CRITERIA; INDEX;
D O I
10.46497/ArchRheumatol.2022.9217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: This study aims to evaluate the expression pattern of factor H in peripheral blood and the frequency of factor H autoantibodies in plasma of juvenile-onset systemic lupus erythematosus (jSLE) patients compared to healthy controls. Patients and methods: Between March 2019 and October 2019, a total of 30 healthy individuals (3 males, 27 females; mean age: 26 +/- 7.4 years; range, 18 to 40 years) and 65 jSLE patients (age of onset =16 years) (2 males, 63 females; mean age: 23.4 +/- 7 years; range, 15 to 38 years) were included. Factor H expression pattern was examined in blood of all subjects using quantitative real-time polymerase chain reaction and the frequency of factor H autoantibodies was estimated in plasma using enzyme-linked immunosorbent assay. Results: Factor H expression was significantly downregulated in jSLE patients compared to healthy controls (p<0.01). A significant underexpression of factor H was observed in jSLE patients with nephritis compared to those without nephritis (p<0.03), while there was no association of factor H expression levels with any of the other clinical and serological features, disease activity or disease damage index of patients. Only 5% of jSLE patients were positive for factor H autoantibodies without any correlations with the clinical data or disease activity of patients. Conclusion: Our study results suggest that factor H expression can be dysregulated in jSLE patients.
引用
收藏
页码:417 / 423
页数:7
相关论文
共 50 条
  • [31] The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus
    Ballantine, Lucy E.
    Ong, Joanne
    Midgley, Angela
    Watson, Louise
    Flanagan, Brian F.
    Beresford, Michael W.
    PEDIATRIC RHEUMATOLOGY, 2014, 12
  • [32] Juvenile-onset systemic lupus erythematosus (jS']jSLE) - Pathophysiological concepts and treatment options
    Hedrich, Christian M.
    Smith, Eve M. D.
    Beresford, Michael W.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2017, 31 (04): : 488 - 504
  • [33] Health Related Quality of Life in Juvenile-Onset Systemic Lupus Erythematosus: A Questionnaire-Based Study
    Eid, Riham
    Hammad, Ayman
    Korkor, Mai S.
    Fathy, Aya A.
    Abd El-Ghafaar, Dena M.
    Rakha, Shaimaa
    Hamdy, Nashwa
    MATERNAL AND CHILD HEALTH JOURNAL, 2023, 27 (09) : 1578 - 1588
  • [34] Comparison of juvenile and adult onset systemic lupus erythematosus
    Baqai, Tanya
    Ioannou, Yiannis
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (10) : 558 - 563
  • [35] Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients
    Eissa, Eman
    Kandil, Rania
    Dorgham, Dalia
    Ghorab, Raghda
    Kholoussi, Naglaa
    PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [36] Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients
    Eman Eissa
    Rania Kandil
    Dalia Dorgham
    Raghda Ghorab
    Naglaa Kholoussi
    Pediatric Rheumatology, 22
  • [37] Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis
    Lythgoe, H.
    Morgan, T.
    Heaf, E.
    Lloyd, O.
    Al-Abadi, E.
    Armon, K.
    Bailey, K.
    Davidson, J.
    Friswell, M.
    Gardner-Medwin, J.
    Haslam, K.
    Ioannou, Y.
    Leahy, A.
    Leone, V.
    Pilkington, C.
    Rangaraj, S.
    Riley, P.
    Tizard, E. J.
    Wilkinson, N.
    Beresford, M. W.
    LUPUS, 2017, 26 (12) : 1285 - 1290
  • [38] Increased Serum Concentration of Sphingosine-1-phosphate in Juvenile-onset Systemic Lupus Erythematosus
    Watson, L.
    Tullus, K.
    Marks, S. D.
    Holt, R. C. L.
    Pilkington, C.
    Beresford, M. W.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (05) : 1019 - 1025
  • [39] Severe Juvenile-Onset Systemic Lupus Erythematosus: A Case Series-Based Review and Update
    Huerta-Calpe, Sergi
    Del Castillo-Velilla, Ignacio
    Felipe-Villalobos, Aida
    Jordan, Iolanda
    Hernandez-Platero, Lluisa
    CHILDREN-BASEL, 2023, 10 (05):
  • [40] A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus
    Cintron, D.
    Alanis, J. M.
    Alvarez-Villalobos, N.
    Rodriguez-Gutierrez, R.
    Vila, L. M.
    LUPUS, 2020, 29 (03) : 303 - 310